Increased level of cell-free placental mRNA in a subgroup of placenta previa that needs hysterectomy

Prenatal Diagnosis

Volumn 28, Issue 9, 2008, Pages 805-809

  Miura, Kiyonori ^a   Miura, Shoko ^a   Yamasaki, Kentaro ^a   Yoshida, Atsushi ^a   Yoshiura, Koh Ichiro ^a   Nakayama, Daisuke ^a   Niikawa, Norio ^b   Masuzaki, Hideaki ^a  

^a NAGASAKI UNIVERSITY GRADUATE SCHOOL OF BIOMEDICAL SCIENCES   (Japan)

^b HEALTH SCIENCES UNIVERSITY OF HOKKAIDO   (Japan)

Author keywords

Cell free placental mRNA; Cesarean hysterectomy; Placenta accreta; Placenta previa; Ultrasonography

Indexed keywords

MESSENGER RNA; PLACENTA LACTOGEN;

ADULT; ARTICLE; CESAREAN SECTION; CLINICAL ARTICLE; CONTROLLED STUDY; ECHOGRAPHY; FEMALE; HORMONE BLOOD LEVEL; HUMAN; HUMAN TISSUE; HYSTERECTOMY; MATERNAL PLASMA; PLACENTA ACCRETA; PLACENTA PREVIA; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; COHORT STUDIES; FEMALE; HUMANS; HYSTERECTOMY; PILOT PROJECTS; PLACENTA ACCRETA; PLACENTA PREVIA; PREDICTIVE VALUE OF TESTS; PREGNANCY; RNA, MESSENGER; ULTRASONOGRAPHY, PRENATAL;

EID: 55449121868     PISSN: 01973851     EISSN: 10970223     Source Type: Journal    
DOI: 10.1002/pd.2056     Document Type: Article

References (17)

1. Comstock CH. 2005. Antenatal diagnosis of placenta accreta: a review. Ultrasound Obstet Gynecol 26: 89-96.
2. Comstock CH, Love JJ Jr, Bronsteen RA, et al. 2004. Sonographic detection of placenta accreta in the second and third trimesters of pregnancy. Am J Obstet Gynecol 190: 1135-1140.
3. Finberg HJ, Williams JW. 1992. Placenta accreta: prospective sonographic diagnosis in patients with placenta previa and prior cesarean section. J Ultrasound Med 11: 333-343.
4. Kupferminc MJ, Tamura RK, Wigton TR, Glassenberg R, Socol ML. 1993. Placenta accreta is associated with elevated maternal serum alpha-fetoprotein. Obstet Gynecol 82: 266-269.
5. Lo YM, Chiu RW. 2007. Prenatal diagnosis: progress through plasma nucleic acids. Nat Rev Genet 8: 71-77.
6. Maron JL, Bianchi DW. 2007. Prenatal diagnosis using cell-free nucleic acids in maternal body fluids: a decade of progress. Am J Med Genet C Semin Med Genet 145: 5-17.
7. Masuzaki H, Miura K, Yamasaki K, et al. 2005a. Clinical applications of plasma circulating mRNA analysis in cases of gestational trophoblastic disease. Clin Chem 51: 1261-1263.
8. Masuzaki H, Miura K, Yoshiura K, et al. 2005b. Placental mRNA in maternal plasma and its clinical application to the evaluation of placental status in a pregnant woman with placenta previa-percreta. Clin Chem 51: 923-925.
9. Mazouni C, Gorincour G, Juhan V, Bretelle F. 2007. Placenta accreta: a review of current advances in prenatal diagnosis. Placenta 28: 599-603.
10. Miura K, Yamasaki K, Miura S, et al. 2007. Circulating cell-free placental mRNA in the maternal plasma as a predictive marker for twin-twin transfusion syndrome. Clin Chem 53: 1167-1168.
11. Ng EK, Leung TN, Tsui NB, et al. 2003a. The concentration of circulating corticotropin-releasing hormone mRNA in maternal plasma is increased in preeclampsia. Clin Chem 49: 727-731.
12. Ng EK, Tsui NB, Lau TK, et al. 2003b. mRNA of placental origin is readily detectable in maternal plasma. Proc Natl Acad Sci U S A 100: 4748-4753.
13. Oyelese Y, Smulian JC. 2006. Placenta previa, placenta accreta, and vasa previa. Obstet Gynecol 107: 927-941.
14. Purwosunu Y, Sekizawa A, Koide K, et al. 2007. Cell-free mRNA concentrations of plasminogen activator inhibitor-1 and tissue-type plasminogen activator are increased in the plasma of pregnant women with preeclampsia. Clin Chem 53: 399-404.
15. Sekizawa A, Jimbo M, Saito H, et al. 2002. Increased cell-free fetal DNA in plasma of two women with invasive placenta. Clin Chem 48: 353-354.
16. Tjoa ML, Jani J, Lewi L, et al. 2006. Circulating cell-free fetal messenger RNA levels after fetoscopic interventions of complicated pregnancies. Am J Obstet Gynecol 195: 230-235.
17. Zelop C, Nadel A, Frigoletto FD Jr, Pauker S, MacMillan M, Benacerraf BR. 1992. Placenta accreta/percreta/increta: a cause of elevated maternal serum alpha-fetoprotein. Obstet Gynecol 80: 693-694.